Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 19.466
Filter
4.
Vestn Oftalmol ; 140(2): 78-82, 2024.
Article in Russian | MEDLINE | ID: mdl-38742502

ABSTRACT

Diabetic vitreopapillary traction syndrome (VPT) is a variant of diabetic retinopathy (DR) that can lead to vision loss in advanced stages. This review reports on the biomechanics of the vitreous in the pathogenesis of proliferative DR, in particular diabetic VPT. The article analyzes and summarizes literature data, presents the views of different authors on this problem, and provides the results of Russian and foreign scientific research on this pathology. It is concluded that further research in this area can lead to a significant improvement in the results of therapy, timely diagnosis, and preservation of vision in patients with DR.


Subject(s)
Diabetic Retinopathy , Vitreous Body , Humans , Diabetic Retinopathy/diagnosis , Diabetic Retinopathy/physiopathology , Diabetic Retinopathy/therapy , Vitreous Body/physiopathology , Biomechanical Phenomena , Syndrome , Vitreoretinopathy, Proliferative/physiopathology , Vitreoretinopathy, Proliferative/etiology , Vitreoretinopathy, Proliferative/diagnosis , Vitreoretinopathy, Proliferative/therapy
5.
Int Ophthalmol ; 44(1): 225, 2024 May 15.
Article in English | MEDLINE | ID: mdl-38748185

ABSTRACT

PURPOSE: To evaluate the importance of the status of posterior vitreous in eyes with endophthalmitis following intravitreal anti-vascular endothelial growth factor (anti-VEGF). METHODS: The absence or existence of posterior vitreous detachment (PVD) was elicited in 23 eyes of 23 patients with injection related endophthalmitis, during pars plana vitrectomy (PPV) and compared with 24 control eyes of 24 patients who received intravitreal anti-VEGF without any complication. RESULTS: Thirtten (54.2%) out of 24 patients in the control group had full PVD, whereas only 2 (9.5%) out of 23 eyes in endophthalmitis group (p < 0.001) had full PVD. In all eyes without PVD, posterior vitreous was inducted to be detached at least from optic nerve and macular area without any iatrogenic tear. CONCLUSION: The absence of PVD is a factor that increases the risk of endophthalmitis after intravitreal injections. Uncomplicated separation of the posterior vitreous from the retina in PPV contributes to better prognosis.


Subject(s)
Angiogenesis Inhibitors , Endophthalmitis , Intravitreal Injections , Vascular Endothelial Growth Factor A , Vitrectomy , Vitreous Detachment , Humans , Endophthalmitis/etiology , Endophthalmitis/diagnosis , Endophthalmitis/epidemiology , Intravitreal Injections/adverse effects , Male , Female , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/adverse effects , Risk Factors , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Aged , Middle Aged , Vitrectomy/adverse effects , Vitrectomy/methods , Vitreous Body , Ranibizumab/administration & dosage , Ranibizumab/adverse effects , Bevacizumab/administration & dosage , Bevacizumab/adverse effects , Aged, 80 and over
6.
Int Ophthalmol ; 44(1): 218, 2024 May 07.
Article in English | MEDLINE | ID: mdl-38713290

ABSTRACT

PURPOSE: To evaluate the levels of anxiety and depression in patients with symptomatic vitreous floaters and to determine the possible correlations of psychological implications with the symptoms duration and possible improvement, the degree of posterior vitreous detachment, and the discomfort severity. METHODS: Ninety patients complaining for floaters and fifty-seven age- and gender-matched healthy-control subjects were recruited. Every participant underwent a complete ophthalmological examination, including funduscopy and optical coherence tomography scans, while clinical and demographic data were also gathered. The Patient Health Questionnaire-9 (PHQ-9), the Zung Depression Inventory-Self-Rating Depression Scale (Zung SDS), and the Hospital Anxiety and Depression Scale (HADS) were completed by everyone. RESULTS: Between the studied groups, no significant differences were detected regarding the clinical and demographic data (p > 0.05). The patients with floaters had significantly higher scores of PHQ-9, Zung SDS, HADS Anxiety, and HADS Depression (p < 0.001). After adjustment for several confounders, PHQ-9 (p = 0.041), Zung SDS (p = 0.003), and HADS Anxiety (p = 0.036) values remained significantly impaired. Among the patients, PHQ-9 and Zung SDS scores were significantly elevated in the patients with floaters duration less than 4 weeks (p < 0.05). Finally, anxiety and depression were significantly correlated with the symptoms duration and intensity, with the floater-associated discomfort, and with the stage of posterior vitreous detachment. CONCLUSION: Vitreous floaters have a negative impact on patients' psychological status, by the terms of enhanced depressive and anxiety levels. To the best of our knowledge, our study is the first in the literature to elaborate the aforementioned association, by assessing three different questionnaires simultaneously.


Subject(s)
Anxiety , Depression , Vision Disorders , Vitreous Body , Humans , Male , Female , Middle Aged , Vitreous Body/diagnostic imaging , Vitreous Body/pathology , Depression/etiology , Depression/diagnosis , Adult , Anxiety/diagnosis , Anxiety/etiology , Eye Diseases/diagnosis , Eye Diseases/psychology , Tomography, Optical Coherence/methods , Surveys and Questionnaires , Aged , Case-Control Studies , Vitreous Detachment/diagnosis , Vitreous Detachment/psychology , Vitreous Detachment/complications
7.
Invest Ophthalmol Vis Sci ; 65(5): 20, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38727692

ABSTRACT

Purpose: Vision-degrading myodesopsia (VDM) from vitreous floaters significantly degrades vision and impacts visual quality of life (VQOL), but the relationship to light scattering is poorly understood. This study compared in vitro measures of light scatter and transmission in surgically excised human vitreous to preoperative indexes of vitreous structure, visual function, and VQOL. Methods: Pure vitreous collected during vitrectomy from 8 patients with VDM had wide-angle straylight measurements and dark-field imaging, performed within 36 hours of vitrectomy. Preoperative VQOL assessment with VFQ-25, contrast sensitivity (CS) measurements with Freiburg acuity contrast testing, and quantitative ultrasonography were compared to light scattering and transmission in vitro. Results: All indices of vitreous echodensity in vivo correlated positively with straylight at 0.5° (R = 0.708 to 0.775, P = 0.049 and 0.024, respectively). Straylight mean scatter index correlated with echodensity (R = 0.71, P = 0.04) and VQOL (R = -0.82, P = 0.0075). Dark-field measures in vitro correlated with degraded CS in vivo (R = -0.69, P = 0.04). VQOL correlated with straylight mean scatter index (R = -0.823, P = 0.012). Conclusions: Increased vitreous echodensity in vivo is associated with more straylight scattering in vitro, validating ultrasonography as a clinical surrogate for light scattering. Contrast sensitivity in vivo is more degraded in the presence of dark-field scattering in vitro and VQOL is decreased in patients whose vitreous has increased light scattering. These findings could form the basis for the development of optical corrections for VDM or support new laser treatments, as well as novel pharmacotherapy.


Subject(s)
Contrast Sensitivity , Light , Scattering, Radiation , Visual Acuity , Vitrectomy , Vitreous Body , Humans , Vitreous Body/diagnostic imaging , Female , Male , Middle Aged , Visual Acuity/physiology , Contrast Sensitivity/physiology , Aged , Quality of Life , Vision Disorders/physiopathology , Adult , Ultrasonography , Eye Diseases/physiopathology , Eye Diseases/diagnostic imaging
8.
Int Ophthalmol ; 44(1): 223, 2024 May 10.
Article in English | MEDLINE | ID: mdl-38727788

ABSTRACT

PURPOSE: This review investigates the therapeutic benefits of interferons (IFNs) in vitreoretinal diseases, focusing on their regulatory roles in innate immunological reactions and angiogenesis. The study aims to categorize the clinical outcomes of IFN applications and proposes a molecular mechanism underlying their action. METHODS: A systematic review was conducted using MEDLINE/PubMed, Web of Science, EMBASE, and Google Scholar databases to identify randomized clinical trials, case series, and case-control studies related to IFNs' impact on vitreoretinal diseases (1990-2022). The data synthesis involved an in-depth analysis of the anti-inflammatory and anti-angiogenesis effects of IFNs across various studies. RESULTS: Our findings indicate that IFNs exhibit efficacy in treating inflammation-associated vitreoretinal disorders. However, a lack of sufficient evidence exists regarding the suitability of IFNs in angiogenesis-associated vitreoretinal diseases like choroidal neovascularization and diabetic retinopathies. The synthesis of data suggests that IFNs may not be optimal for managing advanced stages of angiogenesis-associated disorders. CONCLUSION: While IFNs emerge as promising therapeutic candidates for inflammation-related vitreoretinal diseases, caution is warranted in their application for angiogenesis-associated disorders, especially in advanced stages. Further research is needed to elucidate the nuanced molecular pathways of IFN action, guiding their targeted use in specific vitreoretinal conditions.


Subject(s)
Interferons , Humans , Interferons/therapeutic use , Retinal Diseases/drug therapy , Vitreous Body
9.
Vestn Oftalmol ; 140(2. Vyp. 2): 94-101, 2024.
Article in Russian | MEDLINE | ID: mdl-38739137

ABSTRACT

This case report presents the diagnostic features of isolated primary intraocular lymphoma, which was initially misdiagnosed as neovascular age-related macular degeneration. A comprehensive examination using ultrasound, optical coherence tomography, and fundus autofluorescence revealed changes characteristic of vitreoretinal lymphoma. Molecular genetic analysis of the vitreous body showed the presence of a MYD88 gene mutation and B-cell clonality by immunoglobulin heavy chain (IGH) gene rearrangement tests, which confirmed the diagnosis.


Subject(s)
Retinal Neoplasms , Tomography, Optical Coherence , Vitreous Body , Humans , Vitreous Body/pathology , Vitreous Body/diagnostic imaging , Retinal Neoplasms/diagnosis , Tomography, Optical Coherence/methods , Diagnosis, Differential , Intraocular Lymphoma/diagnosis , Male , Myeloid Differentiation Factor 88/genetics , Fluorescein Angiography/methods , Aged , Eye Neoplasms/diagnosis
10.
Int J Biol Macromol ; 267(Pt 1): 131274, 2024 May.
Article in English | MEDLINE | ID: mdl-38569991

ABSTRACT

The vitreous is a vital component of the eye, occupying a substantial portion of its volume and maintaining its structure. This study delves into the presence and significance of intrinsically disordered proteins (IDPs) within the vitreous, utilizing a dataset of 1240 vitreous proteins previously discovered in the vitreous proteome by Murthy et al.in five healthy subjects. The results indicate that 26.9 % of vitreous proteins are highly disordered, 68.8 % possess moderate disorder, and only 4.3 % are highly ordered. A complex interaction network among these proteins suggests their biological importance, and approximately 25 % may undergo liquid-liquid phase separation (LLPS). These findings offer new perspectives on the vitreous' molecular composition and behavior, potentially impacting our understanding of eye-related diseases, physiological changes such as vitreous syneresis. Further research is needed to translate these insights into clinical applications, although the intrinsic protein disorder and its association with LLPS appears to play a role in vitreous proteome function.


Subject(s)
Intrinsically Disordered Proteins , Proteome , Vitreous Body , Humans , Intrinsically Disordered Proteins/metabolism , Intrinsically Disordered Proteins/chemistry , Proteome/metabolism , Vitreous Body/metabolism , Eye Proteins/metabolism
11.
Invest Ophthalmol Vis Sci ; 65(4): 34, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38648039

ABSTRACT

Purpose: The purpose of this study was to determine if levels of the HtrA1 protein in serum or vitreous humor are influenced by genetic risk for age-related macular degeneration (AMD) at the 10q26 locus, age, sex, AMD status, and/or AMD disease severity, and, therefore, to determine the contribution of systemic and ocular HtrA1 to the AMD disease process. Methods: A custom-made sandwich ELISA assay (SCTM ELISA) for detection of the HtrA1 protein was designed and compared with three commercial assays (R&D Systems, MyBiosource 1 and MyBiosource 2) using 65 serum samples. Concentrations of HtrA1 were thereafter determined in serum and vitreous samples collected from 248 individuals and 145 human donor eyes, respectively. Results: The SCTM ELISA demonstrated high specificity, good recovery, and parallelism within its linear detection range and performed comparably to the R&D Systems assay. In contrast, we were unable to demonstrate the specificity of the two assays from MyBioSource using either recombinant or native HtrA1. Analyses of concentrations obtained using the validated SCTM assay revealed that genetic risk at the 10q26 locus, age, sex, or AMD status are not significantly associated with altered levels of the HtrA1 protein in serum or in vitreous humor (P > 0.05). Conclusions: HtrA1 levels in serum and vitreous do not reflect the risk for AMD associated with the 10q26 locus or disease status. Localized alteration in HTRA1 expression in the retinal pigment epithelium, rather than systemic changes in HtrA1, is the most likely driver of elevated risk for developing AMD among individuals with risk variants at the 10q26 locus.


Subject(s)
High-Temperature Requirement A Serine Peptidase 1 , Macular Degeneration , Serine Endopeptidases , Vitreous Body , Aged , Female , Humans , Male , Chromosomes, Human, Pair 10/genetics , Enzyme-Linked Immunosorbent Assay/methods , Genetic Predisposition to Disease , High-Temperature Requirement A Serine Peptidase 1/blood , High-Temperature Requirement A Serine Peptidase 1/genetics , High-Temperature Requirement A Serine Peptidase 1/metabolism , Macular Degeneration/genetics , Macular Degeneration/metabolism , Macular Degeneration/diagnosis , Risk Factors , Sensitivity and Specificity , Serine Endopeptidases/genetics , Serine Endopeptidases/metabolism , Vitreous Body/metabolism
13.
BMC Ophthalmol ; 24(1): 194, 2024 Apr 25.
Article in English | MEDLINE | ID: mdl-38664667

ABSTRACT

BACKGROUND: Vitreoretinal lymphoma (VRL) still represents a diagnostic challenge for retinal specialists. Early diagnosis and treatment are critical for a better prognosis. Several diagnostic tools have proven helpful in the identification of VRL abnormalities. However, swept-source OCT angiography (SS-OCT-A) findings and their long-term follow-up are yet to be explored. CASE PRESENTATION: a 42-year-old man presented with blurred vision in his left eye for 2 weeks. He denied any systemic symptoms. A multimodal imaging examination was performed, raising the clinical suspicion of VRL and guiding the ensuing diagnostic procedures. The patient underwent treatment and at the last FU visit three years later, no disease signs were present on fundus examination, nor on oncologic evaluation. Some novel SS-OCT-A features were identified, and uncommonly reported findings were examined over a long-term follow-up. At baseline multiple hyperreflective alterations were detected on the enface outer retina slabs and choriocapillary analysis revealed low reflectance areas in the foveal and parafoveal areas. One month after the first presentation, multiple hyperreflective retinal lesions in a vertical shape were detected on OCT which appeared on midretinal slabs of enface SS-OCT-A as hyperreflective spots mainly located near second-order retinal vessels. These alterations remarkably reduced after treatment. CONCLUSION: SS-OCT-A may be a useful imaging technique in the detection of VRL, providing ophthalmologists additional findings that assist the diagnosis and follow-up of this disease. This may prove useful for a more timely and precise diagnosis, prompt therapy, and treatment response monitoring. The original aspects found in this case may provide grounds for future studies, ultimately fostering a better understanding of the disease.


Subject(s)
Fluorescein Angiography , Retinal Neoplasms , Tomography, Optical Coherence , Humans , Male , Tomography, Optical Coherence/methods , Adult , Retinal Neoplasms/diagnostic imaging , Retinal Neoplasms/diagnosis , Fluorescein Angiography/methods , Follow-Up Studies , Vitreous Body/pathology , Vitreous Body/diagnostic imaging , Visual Acuity , Fundus Oculi , Intraocular Lymphoma/diagnosis , Intraocular Lymphoma/diagnostic imaging
14.
BMC Ophthalmol ; 24(1): 171, 2024 Apr 16.
Article in English | MEDLINE | ID: mdl-38627705

ABSTRACT

BACKGROUND: To explore the safety of Neodymium:Yttrium-aluminum-garnet (Nd:YAG) laser vitreolysis based on the histological examination of the retina and the alteration of vitreous cytokines in the rabbits. METHODS: Nine male New Zealand rabbits underwent Nd:YAG laser vitreolysis of 10 mJ x 500 pulses in the left eyes, while the right eyes were used as controls. Intraocular pressure, color fundus photography, and ultrasound B scan were measured before, as well as 1 day, 4 weeks, and 12 weeks after Nd:YAG laser vitreolysis. Three rabbits were euthanized 1 day, 4 weeks, and 12 weeks after treatment, respectively. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining and hematoxylin-eosin (H&E) staining were used to look for pathological changes in the retina. An enzyme-linked immunosorbent assay (ELISA) was utilized to detect the expression of vascular endothelial growth factor (VEGF) and some inflammatory cytokines, including interferon inducible protein 10 (IP-10), monocyte chemoattractant protein 1 (MCP-1) and interlenkin 6 (IL-6) in the vitreous humor. The ascorbic acid (AsA) and total reactive antioxidant potential (TRAP) in the vitreous humor were also measured. RESULTS: Following Nd:YAG laser vitreolysis, the levels of VEGF, IP-10, MCP-1, IL6, AsA, and TRAP in the vitreous humor did not change substantially (P > 0.05). There were no detectable pathological changes in the retinal tissues, and no apoptotic signal was found. CONCLUSIONS: Rabbits tolerate Nd:YAG laser vitreolysis without observable impact on retinal tissue or the microenvironment of the vitreous.


Subject(s)
Eye Diseases , Laser Therapy , Lasers, Solid-State , Male , Rabbits , Animals , Vascular Endothelial Growth Factor A , Lasers, Solid-State/adverse effects , Chemokine CXCL10 , Vitreous Body/surgery , Eye Diseases/etiology , Retina , Antioxidants , Ascorbic Acid , Laser Therapy/adverse effects
15.
Sci Rep ; 14(1): 9571, 2024 04 26.
Article in English | MEDLINE | ID: mdl-38671086

ABSTRACT

Primary vitreoretinal lymphoma (PVRL) is a rare subtype of DLBCL and can progress into primary central nervous system lymphoma (PCNSL). To investigate the role of chronic antigenic stimulation in PVRL, we cloned and expressed B-cell receptors (BCR) from PVRL patients and tested for binding against human auto-antigens. SEL1L3, a protein with multiple glycosylation sites, was identified as the BCR target in 3/20 PVRL cases. SEL1L3 induces proliferation and BCR pathway activation in aggressive lymphoma cell lines. Moreover, SEL1L3 conjugated to a toxin killed exclusively lymphoma cells with respective BCR-reactivity. Western Blot analysis indicates the occurrence of hyper-N-glycosylation of SEL1L3 at aa 527 in PVRL patients with SEL1L3-reactive BCRs. The BCR of a PVRL patient with serum antibodies against SEL1L3 was cloned from a vitreous body biopsy at diagnosis and of a systemic manifestation at relapse. VH4-04*07 was used in both lymphoma manifestations with highly conserved CDR3 regions. Both BCRs showed binding to SEL1L3, suggesting continued dependence of lymphoma cells on antigen stimulation. These results indicate an important role of antigenic stimulation by post-translationally modified auto-antigens in the genesis of PVRL. They also provide the basis for a new treatment approach targeting unique lymphoma BCRs with ultimate specificity.


Subject(s)
Receptors, Antigen, B-Cell , Humans , Receptors, Antigen, B-Cell/metabolism , Glycosylation , Cell Line, Tumor , Retinal Neoplasms/genetics , Retinal Neoplasms/metabolism , Retinal Neoplasms/pathology , Retinal Neoplasms/immunology , Autoantigens/immunology , Autoantigens/metabolism , Lymphoma, Large B-Cell, Diffuse/genetics , Lymphoma, Large B-Cell, Diffuse/immunology , Lymphoma, Large B-Cell, Diffuse/pathology , Lymphoma, Large B-Cell, Diffuse/metabolism , Female , Male , Vitreous Body/metabolism , Vitreous Body/pathology , Middle Aged , Aged
16.
BMC Ophthalmol ; 24(1): 160, 2024 Apr 10.
Article in English | MEDLINE | ID: mdl-38600458

ABSTRACT

BACKGROUND: To describe a case of bilateral multifocal chorioretinitis as the only presentation of acute West Nile virus (WNV) infection in the absence of neurological involvement. CASE PRESENTATION: A 78-year-old Italian woman was admitted to our emergency department because she noticed blurry vision in both eyes. She did not report fever, fatigue, or neurological symptoms in the last few days. Multimodal imaging showed the presence of bilateral hyperfluorescent lesions with a linear distribution, that corresponded to hypocyanescent spots on indocyanine green angiography. Antibody serology showed the presence of IgM antibodies, IgG antibodies, and ribonucleic acid (RNA) for WNV. Magnetic resonance imaging (MRI) of the brain ruled out central nervous system involvement. Three months later, the patient reported spontaneous resolution of her symptoms and remission of the chorioretinal infiltrates. CONCLUSIONS: In endemic areas, it is important to think of acute WNV infection as an explanatory etiology in cases of multifocal chorioretinitis, even without neurological involvement.


Subject(s)
Chorioretinitis , Eye Infections, Viral , West Nile Fever , West Nile virus , Humans , Female , Aged , West Nile Fever/complications , West Nile Fever/diagnosis , West Nile Fever/epidemiology , Eye Infections, Viral/diagnosis , Chorioretinitis/etiology , Vitreous Body/pathology , Antibodies, Viral
17.
Nutrients ; 16(8)2024 Apr 13.
Article in English | MEDLINE | ID: mdl-38674845

ABSTRACT

Nitrate (NO3-) obtained from the diet is converted to nitrite (NO2-) and subsequently to nitric oxide (NO) within the body. Previously, we showed that porcine eye components contain substantial amounts of nitrate and nitrite that are similar to those in blood. Notably, cornea and sclera exhibited the capability to reduce nitrate to nitrite. To gain deeper insights into nitrate metabolism in porcine eyes, our current study involved feeding pigs either NaCl or Na15NO3 and assessing the levels of total and 15N-labeled NO3-/NO2- in various ocular tissues. Three hours after Na15NO3 ingestion, a marked increase in 15NO3- and 15NO2- was observed in all parts of the eye; in particular, the aqueous and vitreous humor showed a high 15NO3- enrichment (77.5 and 74.5%, respectively), similar to that of plasma (77.1%) and showed an even higher 15NO2- enrichment (39.9 and 35.3%, respectively) than that of plasma (19.8%). The total amounts of NO3- and NO2- exhibited patterns consistent with those observed in 15N analysis. Next, to investigate whether nitrate or nitrite accumulate proportionally after multiple nitrate treatments, we measured nitrate and nitrite contents after supplementing pigs with Na15NO3 for five consecutive days. In both 15N-labeled and total nitrate and nitrite analysis, we did not observe further accumulation of these ions after multiple treatments, compared to a single treatment. These findings suggest that dietary nitrate supplementation exerts a significant influence on nitrate and nitrite levels and potentially NO levels in the eye and opens up the possibility for the therapeutic use of dietary nitrate/nitrite to enhance or restore NO levels in ocular tissues.


Subject(s)
Dietary Supplements , Nitrates , Nitrites , Animals , Nitrates/metabolism , Swine , Nitrites/metabolism , Eye/metabolism , Nitrogen Isotopes , Cornea/metabolism , Diet , Aqueous Humor/metabolism , Vitreous Body/metabolism , Nitric Oxide/metabolism , Animal Feed/analysis
19.
BMC Ophthalmol ; 24(1): 193, 2024 Apr 25.
Article in English | MEDLINE | ID: mdl-38664679

ABSTRACT

BACKGROUND: We aimed to investigate the anatomical features of optical coherence tomography (OCT) and vitreous cytokine levels as predictors of outcomes of combined phacovitrectomy with intravitreal dexamethasone (DEX) implants for idiopathic epiretinal membrane (iERM) treatment. METHODS: A prospective, single-masked, randomized, controlled clinical trial included 48 eyes. They were randomly assigned in a 1:1 ratio to undergo the DEX group (combined phacovitrectomy with ERM peeling and Ozurdex implantation) and control group (phacovitrectomy only). Best-corrected visual acuity (BCVA) and central macular thickness (CMT) were assessed at 1 d, 1 week, 1 month, and 3 months. The structural features of OCT before surgery were analysed for stratified analysis. Baseline soluble CD14 (sCD14) and sCD163 levels in the vitreous fluid were measured using ELISA. RESULTS: BCVA and CMT were not significantly different in the DEX and control groups. Eyes with hyperreflective foci (HRF) at baseline achieved better BCVA (Ptime*group=0.746; Pgroup=0.043, Wald χ²=7.869) and lower CMT (Ptime*group = 0.079; Pgroup = 0.001, Wald χ²=6.774) responses to DEX during follow-up. In all patients, the mean vitreous level of sCD163 in eyes with HRF was significantly higher than that in eyes without HRF (P = 0.036, Z=-2.093) at baseline. In the DEX group, higher sCD163 predicted greater reduction in CMT from baseline to 1 month (r = 0.470, P = 0.049). CONCLUSIONS: We found that intraoperative DEX implantation did not have beneficial effects on BCVA and CMT over a 3-month period in all patients with iERM, implying that the use of DEX for all iERM is not recommended. In contrast, for those with HRF on OCT responded better to DEX implants at the 3-month follow-up and thier vitreous fluid expressed higher levels of sCD163 at baseline. These data support the hypothesis that DEX implants may be particularly effective in treating cases where ERM is secondary to inflammation. TRIAL REGISTRATION: The trail has been registered at Chinese Clinical Trail Registry( https://www.chictr.org.cn ) on 2021/03/12 (ChiCTR2100044228). And all patients in the article were enrolled after registration.


Subject(s)
Biomarkers , Dexamethasone , Aged , Female , Humans , Male , Middle Aged , Biomarkers/metabolism , Dexamethasone/administration & dosage , Dexamethasone/therapeutic use , Drug Implants , Epiretinal Membrane/surgery , Epiretinal Membrane/metabolism , Glucocorticoids/administration & dosage , Glucocorticoids/therapeutic use , Intravitreal Injections , Phacoemulsification , Prospective Studies , Single-Blind Method , Tomography, Optical Coherence/methods , Visual Acuity , Vitrectomy/methods , Vitreous Body/metabolism , Vitreous Body/diagnostic imaging
20.
Invest Ophthalmol Vis Sci ; 65(4): 44, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38687493

ABSTRACT

Purpose: Fungal endophthalmitis is characterized by chronic inflammation leading to the partial or complete vision loss. Herein, we analyzed the transcriptomic landscape of Aspergillus flavus (A. flavus) endophthalmitis in C57BL/6 mice to understand the host-pathogen interactions. Methods: Endophthalmitis was induced by intravitreal injection of A. flavus spores in C57BL/6 mice and monitored for disease progression up to 72 hours. The enucleated eyeballs were subjected to histopathological analysis and mRNA sequencing using the Illumina Nextseq 2000. Pathway enrichment analysis was performed to further annotate the functions of differentially expressed genes (DEGs) and validation of cytokines was performed in vitreous of patients with fungal endophthalmitis using multiplex ELISA. Results: Transcriptomic landscape of A. flavus endophthalmitis revealed upregulated T-cell receptor signaling, PI3K-AKT, MAPK, NF-κB, JAK-STAT, and NOD like receptor signaling pathways. We observed significant increase in the T-cells during infection especially at 72 hours infection along with elevated expression levels of IL-6, IL-10, IL-12, IL-18, IL-19, IL-23, CCR3, and CCR7. Furthermore, host-immune response associated genes, such as T-cell interacting activating receptor, TNF receptor-associated factor 1, TLR1, TLR9, and bradykinin receptor beta 1, were enriched. Histopathological assessment validated the significant increase in inflammatory cells, especially T-cells at 72 hours post-infection along with increased disruption in the retinal architecture. Additionally, IL-6, IL-8, IL-17, TNF-α, and IL-1ß were also significantly elevated, whereas IL-10 was downregulated in vitreous of patients with Aspergillus endophthalmitis. Conclusions: Regulating T-cell influx could be a potential strategy to modulate the excessive inflammation in the retina and potentially aid in better vision recovery in fungal endophthalmitis.


Subject(s)
Adaptive Immunity , Aspergillosis , Aspergillus flavus , Cytokines , Disease Models, Animal , Endophthalmitis , Eye Infections, Fungal , Gene Expression Profiling , Immunity, Innate , Mice, Inbred C57BL , Animals , Aspergillus flavus/genetics , Mice , Eye Infections, Fungal/microbiology , Eye Infections, Fungal/genetics , Eye Infections, Fungal/immunology , Endophthalmitis/microbiology , Endophthalmitis/immunology , Endophthalmitis/genetics , Aspergillosis/microbiology , Aspergillosis/genetics , Aspergillosis/immunology , Adaptive Immunity/genetics , Immunity, Innate/genetics , Cytokines/metabolism , Cytokines/genetics , Transcriptome , Enzyme-Linked Immunosorbent Assay , Vitreous Body/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...